Co-occurring psychiatric and substance use disorders: What’s the fuss? Richard A. Rawson Ph.D. UCLA Integrated Substance Abuse Programs San Diego, California October 2004 What are we talking about? An oversimplified picture of the behavioral healthcare service systems in the US Mental Health Services Substance Abuse Services • Leadership-psychiatrists • Staffing-psychologists, social workers, nurses, MFTs • Role of medications-Substantial • Impact of behavioral therapies research-Substantial • Knowledge of substance use disorders and their treatment Minimal • Role of self-help-Minimal • Leadership-A mixture of recovering addict/alcoholics, business people, professionals • Staffing-paraprofessionals, with increasing role of professionals • Role of medications and behavior therapies-Minimal • Knowledge of psychiatric disorders-Minimal • Role of self-help-Substantial The prototype patients for the current service delivery systems The mental health service system The substance abuse service system • The uncomplicated schizophrenic • The “simple” affective disordered individual • The “pure” bi-polar patient • The “plain vanilla” alcoholic • The addict who uses only heroin • The stimulant dependent individual w/o other psych diagnoses What’s the Problem? • Estimates of psychiatric co-morbidity among clinical populations in substance abuse treatment settings range from 20-80% • Estimates of substance use co-morbidity among clinical populations in mental health treatment settings range from 10-35% * Differences in incidence due to: nature of population served (e.g.: homeless vs. middle class), sophistication of psychiatric diagnostic methods used (psychiatrist or DSM checklist) and severity of diagnoses included (major depression vs. dysthymia). Why are substance use disorders treated in separate systems from other psychiatric disorders? How has the split occurred between substance use disorders and other psychiatric disorders? • Before 1970 in the US, research and treatment for alcoholism and drug abuse were administered out of the National Institute of Mental Health. • A number of factors prompted the separation of alcoholism/drug abuse into their own specialty areas, distinct and separate from general psychiatry. Why are substance use disorders treated in separate systems from other psychiatric disorders? • A pervasive perception existed among the public and policymakers that the professional fields of psychiatry, psychology and medicine were extraordinarily unsuccessful in providing treatment to addicts and alcoholics; and, that there was a tendency within much of organized psychiatry (and psychology) to avoid alcoholics and addicts as inherently untreatable individuals, incapable of insight. Why are substance use disorders treated in separate systems from other psychiatric disorders? • Two major factors prompted the establishment of new institutes in early 1970s: – Sen. Harold Hughes’ promotion of treatment for employees with alcohol problems in the workplace was a major influence in the field of alcoholism. Health insurance began to include alcoholism treatment benefits, EAPs began and NIAAA was created. – Huge increases in drug experimentation in late 1960s and concerns about returning heroin addicted Vietnam Veterans, prompted public concern about drug abuse and prompted the creation of NIDA. Why are substance use disorders treated in separate systems from other psychiatric disorders? • The result was: – National Institute of Mental Health (NIMH) responsible for research on and treatment of psychiatric disorders. – National Institute on Alcoholism and Alcohol Abuse (NIAAA) responsible for research on and treatment for alcoholism and related issues. – National Institute on Drug Abuse (NIDA) responsible for research on and treatment of illicit drug problems (and later nicotine). – Each institute had its own experts, treatment systems, funding streams and each viewed the other as parochial, misinformed and naïve. – Cooperation was uncommon. Why are substance use disorders treated in separate systems from other psychiatric disorders? • Since early 1970s– Within treatment settings, alcoholism and drug abuse disorders are treated within the same treatment system; hence, there are now essentially two service delivery systems: 1. Alcoholism and Other Drug (AOD) system 2. Mental health system – Psychiatry has formally incorporated the study and treatment of substance use disorders as part of psychiatry. DSM and ICD: The “Bibles” Studies on Co-morbidity Most widely cited studies: •Epidemiologic Catchment Area (ECA) study •National Comorbidity Study ECA Study •Epidemiologic Catchment Area (ECA) Study •20,291 interviews at 5 sites •Data Collected 1980 – 1984 •DSM – III Diagnoses Regier, DA, et al. (1990). Comorbidity of Mental Disorders with Alcohol and other Drug Abuse: Results From the Epidemiologic Catchment Area (ECA) Study, JAMA, 264, 2511-2518 ECA DSM-III Diagnoses (rates per 100 people) 1 Month Lifetime 15.7 32.7 13.0 22.5 Alcohol Dependence 1.7 7.9 Drug Dependence 0.8 3.5 Any Alcohol, Drug or Mental Health Disorder Any Mental Regier, et al. (1990) Lifetime Prevalence and Odds Ratios ECA Study Alcohol 36.6% OR 2.3 Other Drug 53.1% Schizophrenia 3.8% 3.3 6.8% 6.2 Any affective 13.4% 1.9 26.4% 4.7 Anti-social 14.3% 21.0 17.8% 13.4 47.3% 7.1 Any mental Alcohol Regier, 1990 OR 4.5 NC Study •National Comorbidity Study •8,098 interviews across the country •Data collected 1990 – 1992 •DSM-III-R Diagnoses Merikangas, KR, et al. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: Results o the international consortium in psychiatric epidemiology. Addictive Behavior, 23, 893-907. NCS DSM-III Diagnoses 60 55 50 45 44 41 40 % 37 36 Alc Dep Drug Dep 30 20 10 0 Mood Merikangas, KR, et al. (1998) Anxiety Antisocial NCS DSM-III Diagnoses 4.5 4 4.0 3.7 3.5 OR 3 2.5 2 3.0 2.6 1.8 2.2 Alc Dep Drug Dep 1.5 1 0.5 0 1 2 3 Number of mental disorders Merikangas, KR, et al. (1998) Summary • There is a problem • We have documented it for a long time • We need more information to figure out – The current state of affairs – What we do about it Treatment of Co-occurring Disorders • Treatment System Paradigms – – – – Independent, disconnected Sequential, disconnected Parallel, connected Integrated Treatment of Co-occurring Disorders • Independent, disconnected “model” – Result of very different and somewhat antagonistic systems – Contributed to by different funding streams – Fragmented, inappropriate and ineffective care Treatment of Co-occurring Disorders • Sequential Model – Treat SA Disorder, then MH disorder – Treat MH Disorder, then SA disorder – Urgency of needs often makes this approach inadequate – Disorders are not completely independent – Diagnoses are often unclear and complex Treatment of Co-occurring Disorders • Parallel Model – Treat SA disorder in SA system, while concurrently treating MH disorder in MH system. Connect treatments with ongoing communication – Easier said than done – Languages, cultures, training differences between systems – Compliance problems with patients Treatment of Co-occurring Disorders • Integrated Model – Model with best conceptual rationale – Treatment coordinated best – Challenges • • • • Funding streams Staff integration Threatens existing system Short term cost increases (better long term cost outcomes). Elements of an integrated model • Staffing – A true team approach including: Psychiatrist (trained in addiction medicine/psychiatry); Nursing support; Psychologist; Social worker; Marriage and family therapist; Counselor with familiarity with self-help programs. (Others possible, vocational, recreational educational specialists). Elements of an Integrated Model • Preliminary assessment of mental health and substance use urgent conditions – – – – Suicidality Risk to self or others Withdrawal potential Medical risks associated with alcohol/drug use Elements of an integrated model • Diagnostic process that produces provisional diagnosis of psychiatric and substance use disorders using: – Urine and breath alcohol tests – Review of signs and symptoms (psychiatric and substance use) – Personal history timeline of symptom emergence (what started when) – Family history of psychiatric/substance use disorders – Psychiatric/substance use treatment history Elements of an integrated model • Initial treatment plan that includes (min- one day-max ten days): – Choice of a treatment setting appropriate to initially stabilize medical conditions, psychiatric symptom and drug/alcohol withdrawal symptoms – Initiation of medications to control urgent psychiatric symptoms (psychotic, severe anxiety, etc) – Implementation of medication protocol appropriate for treating withdrawal syndrome(s) – Ongoing assessment and monitoring for safety, stabilization and withdrawal Elements of an integrated model • Early stage treatment plan that includes ( min day 2max day 14) – Selection of treatment setting/housing with adequate supervision – Completion of withdrawal medication – Review of psychiatric medications – Completion of assessment in all domains (psychology, family, educational, legal, vocational, recreational) – Initiation of individual therapy and counseling (extensive use of motivational strategies and other techniques to reduce attrition) – Introduction to behavioral skills group and educational groups – Introduction to self help programs – Urine testing and breath alcohol testing Elements of an integrated model • Intermediate treatment plan that includes (up to six weeks): – Housing plan that addresses psychiatric and substance use needs – Plan of ongoing medication for psychiatric and substance use treatment with strategies to enhance compliance – Plan of individual and group therapies and psychoeducation with attention to both psychiatric and substance use needs – Skills training for successful community participation and relapse prevention – Family involvement in treatment processes – Self-help program participation – Process of monitoring treatment participation (attendance and goal attainment – Urine and breath alcohol testing Elements of an integrated model • Extended treatment plan that includes (up to 6 months): – Housing plan – Ongoing medication for psych and substance use treatment – Plan of individual and group therapies and psychoeducation with attention to both psychiatric and substance use needs – Ongoing participation in relapse prevention groups and appropriate behavioral skills groups and family involvement – Initiation of new skill groups (e.g.; education, vocational, recreational skills) – Self help involvement and ongoing testing – Monitoring attendance and goal attainment Elements of an integrated model • Ongoing plan of visits for review of: – – – – – Medication needs Individual therapies Support groups for psych and substance use conditions Self help involvement Instructions to family to recognize relapse to psych and substance use In short, a chronic care model is used to reduce relapse and if/when relapse (psychiatric or substance use) occurs, treatment intensity can be intensified. Building integrated models • Challenges of building an integrated model – – – – Cost of staffing Training of staff Resistance from existing system Providing comprehensive, integrated care with efficient protocols – The most likely strategy for moving toward this system is in increments • • • • Psychiatrist attend at AOD centers Relapse prevention groups introduced to mental health centers Staff exchanges; attending case conferences; joint trainings Gradual shifting of funding Treatment of Co-occurring Disorders: Areas of Promise • Integration of SA treatment and treatment of affective disorders – Depression • Use of tricyclics and SSRIs produces excellent treatment response in SA patients with depression. Can be used with SA populations with minimal controversy. • Good evidence of effectiveness with methadone patients, women with alcoholism and depression. Treatment of Co-occurring Disorders: Areas of Promise • Bipolar Disorder and SA Disorders – Medications for BPD often essential to stabilize patients to allow SU treatment to be effective – Challenges often occur in diagnosis • Cocaine/methamphetamine use disorders often mimic BPD, medications for these disorders not yet with demonstrated efficacy and do not respond to medications for bipolar disorders Treatment of Co-occurring Disorders: Areas of Promise • Schizophrenia and SU Disorders – Differential diagnosis with cocaine and methamphetamine psychosis can be difficult. – Medication treatments frequently essential. – Knowledge about medication side effects and the possibility that these side effects can trigger drug use is important. Treatment of Co-occurring Disorders: Areas of Promise • Understanding of neurobiological mechanisms and genetic foundations may provide key knowledge for both sets of disorders. • Key issues in improving treatment effectiveness – Training, training, training – Increased contact between professionals from both systems – Flexibility of funding streams – Training, training, training Treatment of Co-occurring Disorders: Areas of Controversy • Should the treatment of SUDs be fully incorporated within the mental health system(e.g.;Integrated Behavioral Health Agency)? • If yes, will treatment protocols unique to substance abuse system be discarded? • Will funding for SUDs be reduced? Co-Occurring Disorders Center for Excellence (COCE) Subcontractor’s Kick-Off Meeting February 13, 2004 The CDM Group, Inc. Chevy Chase, Maryland Rose M. Urban, M.S.W., J.D., LCSW COCE Executive Project Director The CDM Group, Inc. Co-Occurring Disorders Advances in the Field • • • • • Better definitions Treatment needs better understood Improved screening and assessment Improved systems and processes Evidence-based practices exist Key COD Products and Technology Transfer Initiatives • CSAT’s National Treatment Plan, Changing the Conversation; • CSAT’s Substance Abuse Treatment for Persons with Co-Occurring Disorders TIP; • CMHS’s Co-Occurring Disorders: Integrated Dual Disorders Treatment Implementation Resource Kit; • SAMHSA’s Report to Congress on the Prevention and Treatment of Co-Occurring Disorders and Mental Disorders; • SAMHSA’s Strategies for Developing Treatment Programs for People with Co-Occurring Substance Abuse and Mental Disorders Contributors to Knowledge Base • • • • • • • • Federal agencies Grantees (Including COSIG grantees) States Service providers Consumers Researchers Addiction Technology Transfer Centers (ATTCs) Centers for the Application of Prevention Technologies (CAPTs) • National Mental Health Information Center (NMHIC) SAMHSA’S VISION FOR COD PROVIDE LEADERSHIP AND DIRECTION IN DEFINING AND TRANSFERRING THE LATEST EVIDENCE-BASED PRACTICES/ SYSTEMS, SERVICES, & INFRASTRUCTURE TO ALL LEVELS OF THE COD SERVICE SYSTEM OPERATIONALIZING THE VISION: SAMHSA’S COOCCURRING CENTER FOR EXCELLENCE (COCE) COCE APPROACH COCE will: • Advance a unified substance abuse and mental health approach; • Address all levels of client disorder severity; and • Adapt solutions to the unique needs of each service recipient CRITICAL INPUTS Mental Health, Substance Abuse,& COD Research Federal Policy State Policy SAMHSA’s Mission & Priorities State/Local Experience & Innovation Consumer Needs And Perspectives THE COD SERVICE SYSTEM What is the COCE? COCE: Analysis Integration Priorities COCE GOALS LEADERSHIP IN CLARIFYING Definitions Nosology Measurement Evidence & Consensus-Based Practices Unified Approach AGENDA SETTING Professional Education Practice Improvement Research Policy Workforce Development RESOURCE TO SAMHSA Logistical/Operational Execution/Implementation Informational WORK OF THE COCE ACTIVITIES Training Technical Assistance Training of Trainers Institutes Coordination with other SAMHSA Centers PRODUCTS Templates for Product Development Technical Reports Articles Literature Reviews Models of Change Technology Transfer Principles and Practices Who is the COCE? SAMHSA CSAT CMHS CSAP VISION & LEADERSHIP Insures accuracy and integrity of scientific and clinical content Advises SAMHSA and COCE on planning and conduct of COCE activities EXPERT LEADERSHIP GROUP STEERING COUNCIL Plans and oversees COCE activities SENIOR MANAGEMENT TEAM PLANNING, MANAGEMENT, & ACCOUNTABILITY SENIOR FELLOWS FELLOWS e.g., Richard Ries, MD CONTENT Advises and assists Expert Leaders in developing overall COCE content Provides expert input on specific COD content areas CONSULTANT AND SUBCONTRACTOR POOL IMPLEMENTATION Conducts technical assistance, cross-training, and assists in development of materials The COCE Team • Awarded as a 5-year contract to The CDM Group, Inc. (CDM) on September 29, 2003 in association with: – The National Development Research Institutes (NDRI) – The Center for Behavioral Health, Justice & Public Policy (CBHJPP) at The University of Maryland – The National Opinion Research Center (NORC) at the University of Chicago The COCE Senior Team • Directed by CDM – Rose M. Urban, J.D., M.S.W., Executive Project Director – Jill G. Hensley, M.A., Project Director The COCE Senior Team CDM • Michael Klitzner, Ph.D. – Senior Social Scientist • William Reidy, Jr., M.S.W. – TA/CT Specialist • Sheldon Weinberg, Ph.D. – TA/CT Specialist • Robert O’Brien, Ph.D. – Evaluation Adviser The COCE Senior Team NDRI • Stan Sacks, Ph.D. – Expert Adviser on Co-Occurring Disorders • JoAnn Sacks, Ph.D. - Director of State Technical Assistance (TA) • John Challis, B.A., B.S.W. – Project Director CBHJPP, University of Maryland • Fred Osher, M.D. – Expert Medical Adviser on CoOccurring Disorders NORC • Sam Schildhaus, Ph.D. – Director of the PPG Pilot Evaluation Other COCE Subcontractors • 52 other staff from key subcontractors: • Policy Research Associates, Inc. (PRA) • National Addiction Technology Transfer Center; • Regional ATTCs (Northeast/IRETA, Northwest Frontier, and Pacific Southwest) • National Center on Family Homelessness • The George Washington University • New England Research Institutes, Inc. • Foundations Associates • Potential Collaboration with: • National Association of State Mental Health Program Directors (NASMHPD) • National Association of State Alcohol and Drug Abuse Directors (NASADAD) The COCE Consultants • 227 expert consultants with a range of expertise across disciplines, populations, and service settings, including: – – – – – – – Thomas Backer, Ph.D. Carlo DiClemente, Ph.D. Alan Marlatt, Ph.D. Tom McLellan, Ph.D. Richard K. Ries, M.D. Steven Schinke, Ph.D. Douglas M. Ziedonis, M.D. Providing Guidance: The COCE National Steering Council • • • • • • • • • • • • • • National Association of State Mental Health Program Directors (NASMHPD) – Andrew Hyman, J.D. National Association of State Alcohol and Drug Abuse Directors (NASADAD) State Associations of Addiction Services (SAAS) National Council of Community Behavioral Health (NCCBH) – Jennifer Michaels, M.D. American Association of Addiction Psychiatry (AAAP) – Richard Rosenthal, M.D. National Association of Alcohol and Drug Abuse Counselors (NAADAC) National Mental Health Association (NMHA) Research Community – Richard Ries, M.D. Primary Care Community Consumer/Survivor/Recovery Community – Michael Cartwright Homelessness Community – Ellen Bassuk, M.D. Criminal Justice/Drug Court Community – Joe Coccoza, Ph.D. Tribal/Rural Community – Raymond Daw Trauma/Violence Prevention Community – Lisa Najavits, Ph.D. THE COCE AS A CENTER FOR EXCELLENCE COCE WILL: • Address the wide range of clinical, administrative and systems issues that impact the quality and accessibility of care for persons with COD • Address the needs of a broad range of individuals and organizations including practitioners, researchers and scholars, policy makers, administrators, affected populations, and concerned citizens • Have a multidisciplinary staff who have a common interest in COD and science-to-service • Emphasize knowledge synthesis, research-to-practice, and dissemination • Model its message through the application of management, communications, and dissemination science in its own work • Be responsive to the field’s changing needs and priorities • Take a long term view of system change and system improvement THE COCE AS A CENTER FOR EXCELLENCE COCE IS COMMITTED TO: • Advancing a unified substance abuse and mental health approach; • Addressing all levels of client disorder severity; and • Adapting solutions to the unique needs of each service recipient THE FOUNDATIONS OF COCE’S WORK ARE • Evidence-based treatment models and strategies • Comprehensive and integrated services and systems • Client/consumer focus and cultural competence • Quality improvement process Conceptual Framework TOOLS FORCOCE EXCELLENCE: Services and Service Systems Infrastructure Special Populations Prevention Principles of Care Children and Adolescents Screening Legislation and Regulation Children of Individuals with COD Assessment Standards (Federal, State, Other) Women Treatment Planning Credentialing Gay, Lesbian, BiSexual, Transgendered Treatment Service Staff Development and Training Geriatric Support Services System Coordination Supports Ethnic/ Linguistic Minorities Service Integration Information Systems Homeless System Integration Health Care Finance Criminal Justice Involved Evaluation/Research Persons with Medical Comorbidity Resources * Each category contains several subcategories, allowing greater specificity TOOLS FOR EXCELLENCE: COCE SCIENCE TO SERVICE PROCESS SCIENCE-BASED CODFramework PRINCIPLES COCE Conceptual COD SCIENTIFIC BASE – e.g. COD TIP POSITION PAPERS & TECHNICAL REPORTS – e.g. PRODUCTS – e.g. Training Definitions Technical Assistance OTHER TIPS COD TOOL KIT REPORT TO CONGRESS NEW FREEDOM INITIATIVE Screening Assessment & Treatment Planning Monographs Treatment Services Curricula Training and Workforce Development Fact Sheets Etc. Etc. TOOLS FOR EXCELLENCE: THE COCE BRAIN TRUST EXPERT LEADERSHIP GROUP Stan Sacks, Ph.D. Fred Osher, M.D. Rose Urban, J.D., MSW SENIOR FELLOWS e.g., Richard Ries, M.D. STEERING COUNCIL FELLOWS COCE’s Target Audiences • States that have received Incentive Grants for Treatment of Persons with Co-Occurring Substance Related and Mental Disorders (COSIGs) • States selected for the COD Policy Academy • Selected Data Incentive Grant (DIG) States and State Data Infrastructure (SDI) Grants • Sub-State entities including cities, counties, tribes and tribal organizations • Providers (community-based, educational establishments, homelessness system, criminal justice, other social and public health) The COCE Technology Transfer Approach CRITICAL INPUTS Mental Health, Substance Abuse, & COD Research Federal Policy State Policy SAMHSA’s Mission & Priorities State/Local Experience & Innovation Technology Transfer Principles: • Relevance • Credibility • Clarity • Feasibility • Psychosocial factors Consumer Needs And Perspectives Practices: • Matching goals to readiness • Interpersonal strategies • Organizational support • Use of: – Translators – Early adopters – Champions • Peer networking • Follow-up and support COCE Technology Transfer Mechanisms • • • • • • • Provide technical assistance Provide training Prepare and distribute state-of-the-art materials on COD Analyze materials and develop taxonomies Design and manage a co-occurring disorders Web site Support regional and National meetings Develop and conduct a pilot evaluation of the co-occurring Performance Partnership Grant (PPG) measures • Sustain technical assistance and cross-training through coordination with SAMHSA’s existing TA/CT sources Technical Assistance • Individual and Group • On-Site • Off-Site – – – – – – Telephone Literature Reviews Networking Web sites General Information Materials, reports, etc. COCE Technical Assistance Delivery Process Post-Delivery Phase Pre-Delivery Phase Off-Site On-Site Off-Site Select TA/CT Providers Field Requests and Assess Needs Plan and Manage Logistics COCE Staff and/or Consultant TA/CT Provider(s) perform TA/CT activities: Telephone Lit Reviews Networking Web site Maintain Files To Inform Similar TA Events Follow-up On-Site TA/CT Delivery Develop TA/CT Plan On Site Off-Site Both Develop Consultation Plan COCE TA Coordinator Support Evaluation and Reporting Interim TA Plan • Pilot of TA Plans and Procedures • Federal Project Officer Reviews and Approves TA Plan Before Services are Provided • Pilot Findings used to Refine Process for FullScale Rollout Training • Training of Trainers (TOT) – Addiction Technology Transfer Centers (ATTCs) – Centers for the Application of Prevention Technology (CAPTs) – States – Provider Organizations (e.g., NCCBH, SAAS) • Cross-Training (CT) • Curriculum Development Materials Development and Analysis • • • • • • • Position Papers Monographs Training Curricula Brochures Newsletter Fact Sheets Program Briefs CLINICAL CAPACITY BUILDING INFRASTRUCTUR E DEVELOPMENT Screening, Assessment, and Treatment Planning Financing Mechanisms Treatment Services Certification and Licensure Terminology, Nosology, Definitions System Integration Training and Workforce Development Services Integration Evaluation and Monitoring Information Sharing COCE Web Site Will be designed to: • Motivate exploration of COD; • Clarify users’ interests and concerns; • Guide users to relevant information; and • Provide users with support in understanding and using information. Regional and National Meetings • Annual National meeting • Three regional meetings in year 1, four regional meetings in years 2-5 – Increase awareness of recent research – Bridge the gaps between research, practice, and policy – Form and sustain relationships among providers across constituencies – Create peer networks – Provide cross-training of providers The COCE Contract Emphasizes Sustainability Early and substantive linkages with: – CSAT’s Addiction Technology Transfer Centers (ATTCs) – CSAP’s Centers for the Application of Prevention Technology (CAPTs) (6 regional centers) – CMHS’s National Mental Health Information Center (NMHIC) Development of sustainable systems of technology transfer Establishment of science-based practices as the norm Impact on agendas of knowledge producers to better meet the needs of a science-to-service model Role of the Subcontractors • Policy Research Associates (PRA) – Criminal Justice Expertise • National Center on Family Homelessness – Homelessness Expertise • George Washington University – Treatment Systems Finance and Organization; Cross-Systems Infrastructure Expertise • New England Research Institutes, Inc. (NERI) – Financial Strategy Development and Analysis Expertise • Foundations Associates (FA) – Consumer/Recovery Community Expertise Role of the ATTCs CURRENT PARTNERS National ATTC NE ATTC NW ATTC SW ATTC • Coordinate ATTC • Work with COCE to • Assist in convening • Assist in convening activities with COCE design and implement a ATTC COD ATTC COD Workgroup activities TOT for ATTCs Workgroup • provide consultation to • Logistical support for • Adapt COCE products • Provide advice and COCE staff on NE ATTC TOTs and services to meet planning concerning developing and/or specific ATTC needs dissemination of COCE revising curricula and • Plan for marketing & knowledge throughout training materials on dissemination of COCE the ATTC system COD for use by the products through ATTCs, particularly with ATTCs • inventory existing respect to evaluating COD-related ATTC • Convene an ATTC treatment outcomes materials/databases; COD Workgroup to assess these for collaborate with COCE suitability for COCE efforts; and assist in revising for SAMHSA content clearance, if Role of the ATTCs CURRENT ATTC PARTNERS Motivate Orient Train OTHER ATTCs MAXIMUM IMPACT THE COD FIELD COCE Timetable Sep 29 – Dec 30, 2003 • Conceptualize Approach and Develop Plans • Initial COSIG Meeting December 15-17 Jan 1 – Mar 31, 2004 • Provide Interim TA • Establish Coordination Mechanisms • Convene National Steering Council • Convene COSIG, DIG, and SDI Grants Involved in the PPG Pilot Evaluation April 1, 2004 • Full TA services • Continued development of – – – – – – COCE infrastructure Linkages TIP Curricula Other materials Web site How to Request COCE Services • Requests for services must be in writing • Direct requests to: – samhsacoce@cdmgroup.com or – COCE Phone Line: 301-951-3369 • Questions? – Jill Hensley, COCE Project Director 301-654-6740 (x 201) – George Kanuck, Federal Project Officer 301-443-8642